British Journal of Pharmacology 2008-02-01

Transient allodynia pain models in mice for early assessment of analgesic activity.

D W Gil, C V Cheevers, J E Donello

Index: Br. J. Pharmacol. 153(4) , 769-74, (2008)

Full Text: HTML

Abstract

The most common preclinical models of neuropathic pain involve surgical ligation of sensory nerves, which is especially difficult in mice. Transient models of chemically sensitized allodynia are potentially useful for rapidly characterizing the analgesic profile of compounds and conducting mechanistic studies.Increasing doses of NMDA, sulprostone (an EP1/EP3 prostaglandin receptor agonist) or phenylephrine (an alpha (1) adrenoceptor agonist) were injected intrathecally (i.t.) or i.p., and animals were subsequently assessed for allodynia. The effects of receptor antagonists and analgesic compounds on allodynia were also assessed.A comparison of total body doses that cause allodynia following spinal or systemic administration indicated that NMDA induces allodynia in the spinal cord while sulprostone and phenylephrine act through a peripheral mechanism. Inhibition of the allodynia with receptor antagonists indicated that each agent induces allodynia by a distinct mechanism. The three models were benchmarked using compounds known to be active in neuropathic pain patients and nerve injury animal models, including gabapentin, amitriptyline and clonidine.These transient allodynia models are a useful addition to the toolbox of preclinical pain models. They are simple, rapid and reproducible, and will be especially useful for characterizing the pain phenotype of knockout mice.


Related Compounds

Related Articles:

Cell membrane chromatography competitive binding analysis for characterization of α1A adrenoreceptor binding interactions.

2011-07-01

[Anal. Bioanal. Chem 400(10) , 3625-33, (2011)]

Influence of high dietary sodium intake on the functional subtypes of alpha-adrenoceptors in the renal cortical vasculature of Wistar-Kyoto rats.

2009-01-01

[Auton. Autacoid Pharmacol. 29(1-2) , 25-31, (2009)]

Alpha-1A adrenergic receptor activation increases inhibitory tone in CA1 hippocampus.

2009-04-01

[Epilepsy Res. 84(2-3) , 97-109, (2009)]

Pharmacological characterization of alpha1- and beta-adrenergic synergism of 5'DII activity in rat brown adipocytes.

2006-02-01

[Arch. Physiol. Biochem. 112(1) , 23-30, (2006)]

Influence of cisplatin-induced renal failure on the alpha(1)-adrenoceptor subtype causing vasoconstriction in the kidney of the rat.

2007-08-13

[Eur. J. Pharmacol. 569(1-2) , 110-8, (2007)]

More Articles...